- Home
- KNSA vs CUBI Comparison
KNSA vs CUBI Comparison
Compare KNSA & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- CUBI
- Stock Information
- Founded
- KNSA 2015
- CUBI 1994
- Country
- KNSA United Kingdom
- CUBI United States
- Employees
- KNSA N/A
- CUBI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- CUBI Major Banks
- Sector
- KNSA Health Care
- CUBI Finance
- Exchange
- KNSA Nasdaq
- CUBI Nasdaq
- Market Cap
- KNSA 1.9B
- CUBI 1.6B
- IPO Year
- KNSA 2018
- CUBI 2012
- Fundamental
- Price
- KNSA $27.36
- CUBI $50.94
- Analyst Decision
- KNSA Strong Buy
- CUBI Buy
- Analyst Count
- KNSA 5
- CUBI 10
- Target Price
- KNSA $38.80
- CUBI $65.67
- AVG Volume (30 Days)
- KNSA 474.9K
- CUBI 182.6K
- Earning Date
- KNSA 07-22-2025
- CUBI 07-24-2025
- Dividend Yield
- KNSA N/A
- CUBI N/A
- EPS Growth
- KNSA N/A
- CUBI N/A
- EPS
- KNSA N/A
- CUBI 3.98
- Revenue
- KNSA $481,166,000.00
- CUBI $591,500,000.00
- Revenue This Year
- KNSA $37.21
- CUBI $13.40
- Revenue Next Year
- KNSA $5.32
- CUBI $11.22
- P/E Ratio
- KNSA N/A
- CUBI $12.79
- Revenue Growth
- KNSA 59.45
- CUBI N/A
- 52 Week Low
- KNSA $17.38
- CUBI $40.75
- 52 Week High
- KNSA $28.56
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- KNSA 62.48
- CUBI 48.41
- Support Level
- KNSA $26.28
- CUBI $50.57
- Resistance Level
- KNSA $27.90
- CUBI $52.48
- Average True Range (ATR)
- KNSA 0.99
- CUBI 1.11
- MACD
- KNSA -0.07
- CUBI -0.37
- Stochastic Oscillator
- KNSA 82.30
- CUBI 19.71
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.